home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Arcadia Biosciences welcomes Chief Financial Officer - Experienced life science executive will strengthen company’s financial capabilities 


Davis, California, USA
March 12, 2015

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that Thomas P. O’Neil has joined the company’s leadership team as chief financial officer (CFO).

Mr. O’Neil brings more than 20 years of finance and operations experience in private and large public companies in the U.S. and globally. Prior to joining Arcadia, Mr. O’Neil was the CFO of Sorbent Therapeutics, Inc. He has also held executive-level positions with ChemGenex Pharmaceuticals, a publicly traded Australian company, and biotechnology firms Nodality and HX Diagnostics, as well as several finance roles with Monogram Biosciences, Inc., a publicly traded U.S. company. Mr. O’Neil’s experience includes initial public offerings, oversight and management of equity and debt financings, mergers and acquisitions, collaborations, and investor relations. He has an M.B.A. from the University of California, Los Angeles, Anderson Graduate School of Management, and a B.A. from Pomona College.

“Tom has a strong track record of driving growth in life sciences businesses and brings a broad set of skills that will expand the capabilities and capacity of our finance and management teams,” said Eric Rey, president and CEO. “He is a proven communicator with the ability to build the internal and external partnerships necessary to manage growth.”

“With compelling partnerships in place, an extensive development pipeline, and a strong management team, this is an exciting time to join Arcadia,” said Mr. O’Neil. “I look forward to working with Eric and the team to build the company and advance its mission to improve the productivity of agriculture and its impact on the environment.”

About Arcadia Biosciences, Inc.

Based in Davis, Calif., with additional facilities in Seattle, Wash. and Phoenix, Ariz., Arcadia Biosciences is focused on developing agricultural products that benefit the environment and enhance human health. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. Arcadia’s nutrition technologies and products are aimed at creating healthier ingredients and whole foods with lower production costs. The company was recently listed in the Global Cleantech 100, representing the most innovative and promising ideas in clean technology, and was previously named one of MIT Technology Review's 50 Smartest Companies. For more information, visit www.arcadiabio.com.



More news from: Arcadia Biosciences


Website: http://www.arcadiabio.com

Published: March 12, 2015

The news item on this page is copyright by the organization where it originated
Fair use notice

 

 

 

 

 

 

 

 

 

 


Copyright @ 1992-2024 SeedQuest - All rights reserved